A recombinant plasmid designated pLVS3 previously was described that harbored a 14-kilobase insert of Treponema pallidum genomic DNA. Escherichia coli maxicells programmed with this plasmid synthesized three treponemal protein antigens of molecular weights 39,000, 35,000, and 25,000 (39K, 35K, and 25K proteins, respectively). In this study, a detailed deletion analysis of pLVS3 demonstrated that the genetic information for all three protein antigens is contained within a 1.5-kilobase EcoRI-HpaI restriction fragment. The DNA sequence of this fragment revealed a single open reading frame of 361 codons that most likely encodes a signal peptide-bearing precursor to the 39K protein that can be transiently detected in E. coli maxiceils. Evidence indicated that the 35K and 25K protein antigens are derivatives of the larger protein and are only produced in maxicells. A significant elevation in expression of the 39K treponemal protein antigen in E. coli was obtained by using the E. coli lpp and lac promoters and a genetic construction in which the signal peptide and first four residues of the "mature" 39K protein were replaced by six amino acids encoded by the vector. This hybrid protein exhibited an unusually high pl, which greatly facilitated its purification to homogeneity. By using antibody prepared against the hybrid protein, the native treponemal protein counterpart, also of molecular weight 39,000, was identified as a membrane component of T. paUidum. Since the native protein also exhibited a net positive charge, it has been designated the T. pallidum basic membrane protein.
The bacterium Treponema pallidum, the etiological agent of syphilis, cannot be continuously cultivated in vitro. To obtain treponemes for experimental analyses, the organism usually is cultivated in rabbit testes, from which it can be extracted and purified in only limited quantities. For this reason, little has been learned concerning the virulence determinants of T. pallidum or about the immunogenic determinants responsible for eliciting a protective host immune response. Despite the experimental difficulties, researchers have extensively compared the protein profiles of various noncultivable and cultivable treponemal strains by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and defined the various protein antigens of T. pallidum that are reactive with sera from both infected humans and rabbits at different times after infection (3, 5, 15, 16, 26, 30, 44, 47, 50) . Several studies have attempted to identify those protein antigens that reside on the treponemal cell surface (1, 2, 21, 33, 35, 39, 44, 48) , and it has been suggested that several proteins serve as ligands involved in the adherence of treponemes to host tissues (6, 37, 49) . In addition, a unique class of extracellular protein antigens of T. pallidum has been identified (44) .
In recent years, several laboratories have begun applying recombinant DNA technology to the study of T. pallidum, in hopes of at least partially circumventing problems associated with the cultivation of this organism (11, 17, 31, 39, 43, 45, 46, 54) . It was anticipated that recombinant treponemal proteins would be conveniently produced in sufficient quantities such that their role in syphilis and possibly other human treponematoses could be defined and their applicability as vaccinogens or improved serodiagnostic reagents could be investigated.
A recombinant plasmid, pLVS3, was initially identified by screening Escherichia coli clones for the expression of antigens recognized in an in situ assay by high-titer rabbit and human syphilitic sera (45) . Subsequently, this plasmid was found to encode three T. pallidum protein antigens of molecular weights 39 ,000, 35,000, and 25,000 (39K, 35K, and 25K proteins, respectively) (46) . Although the native T. pallidum counterparts to these proteins were not known, the 39K protein was of particular interest for several reasons.
First, there was an indication that this protein is initially synthesized with an amino-terminal signal peptide that would direct this protein to some extracytoplasmic compartment in E. coli and T. pallidum (46) . Second, the evidence indicated that E. coli cells harboring plasmid pLVS3 expressed treponemal antigens on their cell surface (43, 45) . Third, this protein was recognized by virtually every human syphilitic serum tested, including sera from patients with known primary, secondary, latent, and late cardiovascular syphilis (46) . Thus, it was thought that this protein might have value as a serodiagnostic reagent for syphilis.
In this study, the nucleotide sequence of the gene encoding the 39K protein has been determined. From this sequence and other data, the presence of a signal peptide is strongly indicated. The coding sequence has been cloned into an E. coli expression vector, facilitating purification of a hybrid protein that includes nearly the entire "mature" 39K protein. Rabbit immunoglobulin G (IgG) antibodies prepared BASIC MEMBRANE PROTEIN OF T. PALLIDUM 1107 against the purified protein precipitated a single, 39K membrane protein from a solubilized, radiolabeled T. pallidum cell extract. The purified, recombinant protein was found to have an unusually high pI. Additional evidence indicated that the native 39K protein also was quite basic. For these reasons, the 39K protein encoded by plasmid pLVS3 has been designated the T. pallidum basic membrane protein (BMP).
MATERIALS AND METHODS
Bacterial strains, phage, and plasmids. M13 phage derivatives and pUC8 derivatives were propagated in E. coli JM103 (32) . All other plasmids were propagated in strain MM294 (ATCC 33625). Strain SE5000 (46) was used for maxicell analyses in pulse-chase experiments. Strain MC4100 (9) was used for protein purification. Phage M13mpl8 was used for determining the bmp DNA sequence (32) . The plasmid pLVS3 is a pBR322 derivative harboring a 14-kilobase insert of T. pallidum genomic DNA (27) , and pUC8 is a plasmid with a multiple cloning site region (52) . The expression vectors pIN-III-A2 and pIN-III-A3 have been described previously (27) . The source and cultivation of T. pallidum (Nichols strain) were previously described (46) . DNA isolation, enzyme reactions, gel electrophoresis, and transformation. Plasmid DNA was isolated using an alkaline lysis method for both minipreparations and equilibrium density centrifugation (38) . All enzymes were purchased from Bethesda Research Laboratories, Gaithersburg, Md., and restriction enzyme and ligase reaction conditions were as described by O'Farrell et al. (34) . Restricted DNA samples were analyzed on vertical agarose slab gels in Trisacetate buffer. Plasmid DNA was transformed into bacterial strains by the method of Hanahan (14) . DNA fragments were isolated from agarose gels by the procedure of Lizardi et al. (24) .
Identification of recombinant T. pallidum protein antigens.
Plasmids were transformed into E. coli SE5000, and [35S]methionine-radiolabeled maxicell extracts were prepared as previously described (46) . Recombinant treponemal protein antigens were immune precipitated from solubilized maxicell extracts by using high-titer experimental rabbit syphilitic serum and analyzed by SDS-PAGE and fluorography as previously described (46 (50 ,ul) of the clarified supernatant of these samples was used as the antigen extract in an immune precipitation procedure identical to one previously described (46) . Samples of 10 Rl of rabbit anti-hybrid BMP (BMP*; see Results) IgG were used for each precipitation reaction. Precipitates were analyzed by SDS-PAGE and fluorography as previously described (46) .
Purification of the BMP*. E. coli MM294 harboring plasmid pTP102 was grown in L broth (29) 23 ,000 x g for 1 h. The pellet was suspended in 400 ml of buffer with an Omnimixer (Sorvall) and centrifuged again. The supernatants were combined (900 ml) and 342 g of solid (NH4)2SO4 was added to the crude extract as the extract was stirred at 4°C. After 30 min, the suspension was centrifuged at 13,000 x g for 20 min, and the supernatant was discarded. The pellet was suspended in 200 ml of 50 mM KPO4 buffer and dialyzed four times against 4 liters of the same buffer. The dialyzed extract (415 ml) was pumped onto a 2.5-by 20-cm column of phosphocellulose that had been equilibrated with the same buffer at a flow rate of 2.0 ml/min. The column was washed with 300 ml of the same buffer. The protein of interest was eluted from the column with 500 ml of 50 mM KPO4 buffer containing 0.2 M LiCl, and 20-ml fractions were collected. The fractions were analyzed by SDS-PAGE (23); the fractions containing the protein were pooled (450 ml), precipitated with (NH4)2SO4, and dialyzed three times against 2 liters of 25 mM KPO4 buffer (pH 7.4). The dialyzed solution was passed through a 2.5-by 10-cm column of DE-52, which was subsequently washed with the same buffer. Fractions of 10 ml were collected, and the absorbance at 280 nm was monitored. Those fractions with an absorbance of greater than 0.05 were pooled and lyophilized. The residue was resuspended in H20 to a total volume of 40 ml; 10-ml samples were chromatographed on a 2.5-by 100-cm G-200 Sephadex column equilibrated in 25 mM KPO4 (pH 7.4) at a flow rate of 12.5 ml/h, and 5-ml fractions were collected. The absorbance at 280 nm was determined, and once again those fractions with an absorbance greater than 0.05 were assayed by SDS-PAGE. Those fractions containing the BMP* were pooled, dialyzed against 4 liters of 10 mM EDTA for 12 h, then dialyzed against H20 for 24 h, and lyophilized.
Protein concentrations were determined by the method of Lowry et al. (25) with bovine serum albumin as the standard. The presence of the protein and its purity were determined by SDS-PAGE (23); protein bands were stained and destained by the method of Ferguson (12) . Molecular weight markers were obtained from Pharmacia Fine Chemicals, Piscataway, N.J. The isoelectric point (pI) of the BMP* was determined by isoelectric focusing as previously described (40) with carrier ampholytes (Pharmylate pH 8 to 10.5 with 10% Pharmylate pH 6 to 8) obtained from Pharmacia.
Preparation of rabbit anti-BMP* serum. Antiserum to the BMP* was obtained from male New Zealand White rabbits. Purified BMP* (1 mg) was suspended in phosphate-buffered saline and mixed 1:1 with incomplete Freund adjuvant to a total volume of 1.0 ml. A 0.2-ml sample was injected into the muscle of each hind leg; booster injections of purified BMP* in phosphate-buffered saline alone were administered at 2-week intervals. After rabbits were bled, the IgG antibody fraction was purified as previously described (10) .
Identification of native BMP. Cells of T. pallidum that had been freshly extracted from infected rabbit testes were intrinsically radiolabeled with [35Slmethionine as previously described (44) . Treponemal fractions were prepared and solubilized, and the native BMP was precipitated with rabbit anti-BMP* IgG and analyzed by SDS-PAGE and fluorography as previously described (44 
RESULTS
Restriction map and deletion analysis of pLVS3. The recombinant plasmid pLVS3 was previously shown to consist of two BamHI fragments of T. pallidum DNA (13,700 and 900 bp) inserted into the single BamHI site of pBR322 (45, 46) . To initiate this study, a more detailed restriction map of pLVS3 was generated (Fig. 2) . By selectively deleting specific DNA fragments with restriction enzymes, a series of smaller plasmids was obtained, some of which are diagramatically presented in Fig. 2 . The effect of each deletion on the expression of the three treponemal protein antigens was then evaluated by using E. coli maxicells to detect plasmid-encoded proteins. The identity of the treponemal proteins was authenticated by immunoprecipitation of radiolabeled maxicell extracts with experimental rabbit syphilitic serum (Fig. 3) . Deletion of either a 6,500-bp HpaI fragment (plasmid pTP001) or a 3,600-bp SstI fragment (plasmid pTP002) resulted in the concomitant loss of synthesis of all three proteins. In contrast, all three proteins were still expressed, albeit in lesser amounts, after deletion of two EcoRI fragments totaling 6,700 bp (plasmid pTP020). This latter plasmid was then used to generate additional deletions, each extending from the unique SalI site located in the vector portion to an SstI site (plasmid pTP022), an HpaI site (pTP025), or an HindIII site (pTP024). Maxicell analysis of each of these plasmids revealed that only the 8,500-bp Sall-HindIII deletion abolished expression of all three protein antigens. Neither of the other deletions eliminated expression of any of the proteins, although the 8,000-bp SalI-SstI deletion in plasmid pTP022 did result in the appearance of an additional higher-molecular-weight immunoreactive protein antigen (Fig. 3) Elevated expression of the BMP. The 1,470-bp fragment was bounded by an EcoRI site and an HpaI site. In an effort to obtain elevated synthesis of the recombinant treponemal proteins in E. coli, this fragment was inserted into the expression vector pIN-III-A2, which uses the E. coli lipoprotein (lppP) and lacUV5 promoters to enhance transcription of cloned DNA (27) . These promoters are followed by the lactose operator (lacO), which permits the regulation of transcription of distal genes by the lactose repressor, whose structural gene is also included on the vector. The HpaI site at one end of the 1,470-bp fragment was converted to an EcoRI site by adding an EcoRI linker to pTP020, thus permitting insertion of the fragment into the unique EcoRI site of plasmid pIN-III-A2 in both possible orientations. Plasmid isolates corresponding to the two insert orientations were identified by restricting with HindIII. Gene expression from two representative plasmids was then analyzed in maxicells (Fig. 4) that the direction of transcription of the bmp gene is from the EcoRI site toward the HpaI site (Fig. 2) .
The nucleotide sequence of the entire EcoRI-HpaI fragment of pLVS3 was determined (Fig. 6 ). An ATG codon was identified at nucleotide 285 (numbering from the EcoRI site), which was preceded by a putative ribosome binding site (GGAG; nucleotides 276 through 279 [42] ) and followed by a long open reading frame capable of encoding a protein of 361 residues. This was the only large open reading frame encountered in this DNA fragment and thus must represent the bmp gene. Interestingly, note that the SstI site used to generate plasmid pTP022 resides just within the 3' end of the coding sequence. Thus, the somewhat anomalous gel behavior of the recombinant BMP in maxicells programmed with this plasmid must result from generation of a recombinant protein with a new carboxy terminus (see above).
As described in Materials and Methods, plasmid pTP107 was constructed, in which the BMP coding sequence from plasmid pLVS3 was placed just downstream from the lacO sequence of plasmid pIN-III-A2. Maxicells programmed with plasmid pTP107 produced a somewhat greater quantity of the BMP than did maxicells programmed with plasmid pTP1O9 (Fig. 4) . This result suggested that the ATG codon at nucleotide 285 was indeed the initiating codon for the BMP.
BMP is initially expressed in E. coli in a precursor form. When the production of the BMP was assayed in whole E. coli cells containing plasmid pTP107, only a small amount of this protein was made. This may be due to an inefficient ribosome-binding site provided by the native treponemal gene. Also, the possibility was considered that low expression was due in part to the localization of this protein when expressed in E. coli. It previously had been suggested that the BMP was synthesized in E. coli with an amino-terminal signal peptide that was subsequently cleaved (46) . Pulsechase studies revealed that the BMP was initially synthesized in maxicells as a larger-molecular-weight precursor form that was slowly processed to its 39K "mature" size (Fig. SA) . Evidence that this higher-molecular-weight form represents an unprocessed signal peptide-bearing precursor is supported by the observation that only this form of the protein was observed when maxicells were labeled in the presence of membrane perturbants, either 0.3% phenethyl alcohol or 10% ethanol, treatments which are known to inhibit signal peptide processing in E. coli (13; data not presented). Attempts to unambiguously determine the intracellular location of the BMP synthesized in E. coli maxicells containing any of the plasmids described above thus far have been unsuccessful, due to the instability of the protein when these cells have been disrupted under nondenaturing conditions (data not presented).
Assuming that the ATG codon at nucleotide 285 initiates translation of the BMP, translation of the downstream DNA sequence revealed a primary amino acid sequence of 20 residues that is fairly typical of procaryotic signal peptides (Fig. 6) (53) . This putative signal peptide includes a charged residue very near its amino terminus followed by a fairly long hydrophobic core and, last, the sequence Ala-X-Ala, which precedes the cleavage site in many nonlipoprotein signal peptides in E. coli (36, 53) . Just beyond this coding region, the DNA sequence identified a PstI site (Fig. 6) . Using this restriction site we generated in vitro a deletion that removed the putative signal peptide-coding region, and subsequent manipulations directed translational initiation of the remaining sequence at a site early in the coding region for the mature BMP (see Materials and Methods). In this plasmid, designated pTP102, translation of the 39K protein was initiated at the lipoprotein ribosome-binding site, and the first four residues of the mature BMP were replaced by six amino acids encoded by the vector (Fig. 7) . This hybrid protein was designated BMP*. When plasmid pTP102 was analyzed in maxicells, enhanced expression of the BMP* was observed (Fig. 4) . As expected, a precursor form for this protein was not discerned in a pulse-chase experiment (Fig.  SB) .
Purification of the recombinant BMP* encoded by plasmid pTP102. When whole cells of strain MM294 harboring plasmid pTP102 were analyzed by SDS-PAGE and Coomassie blue staining, the BMP* could easily be discerned (Fig. 8) . Interestingly, synthesis of the 25K and 35K treponemal protein antigens was not detected. We estimated that production of this protein was elevated approximately 10-fold above the level observed in cells harboring plasmid pTP107. Cells of strain MM294 (pTP102) were disrupted by sonication, and crude membrane and soluble fractions were prepared and analyzed by SDS-PAGE. Under these conditions, the bulk of the BMP* was clearly in the soluble fraction.
The BMP* was purified to homogeneity by conventional techniques, as described in detail in Materials and Methods. Initially after the soluble and membrane wash fractions were pooled and precipitated with (NH4)2SO4, the dialyzed extract was applied to a chromatofocusing column. The protein did not bind to this resin, suggesting that the isoelectric point of this protein was above 7.5 BMP* does not bind) and by molecular sieving (the BMP* to 9) and 1% Triton X-100. The sequence of the aminomigrates either as a monomer or dimer but not as an terminal 25 residues of the purified protein has been deteraggregate). mined (data not presented). This sequence corresponded A summary of the purification procedure is shown in Table   with what was predicted from the DNA sequence and the 1, and an SDS-PAGE analysis of the purified BMP* is genetic construction that yielded plasmid pTP102. presented in Fig. 8 (Fig. 9) . This protein migrated on SDS-PAGE to the same position as the processed BMP encoded by plasmid pTP107 (data not presented). The native BMP was found almost exclusively in the particulate treponemal fraction (Fig. 9) 39, 940 . It appears that this protein includes an amino-terminal signal peptide of 20 residues, assuming that processing occurs immediately after the Ala-His-Ala sequence that resembles the processing site for E. coli leader peptidase (36, 53) . Assuming that this is correct, then the processed form of the protein would have 341 residues with a compositional molecular weight of 37,880, which is very close to the 39,000 molecular weight estimated for this protein from analysis on SDS-PAGE. The recombinant BMP* that was purified from E. coli and that differs only slightly from the native treponemal protein exhibited an unusually high isoelectric point of 9.5, which greatly facilitated its purification. The high pl is not reflected in the protein's primary amino acid sequence, where basic residues outnumber acidic residues only slightly (48 versus 43).
In both this study and a previous study (46) (Fig. 8) (18) . The use of a he presence of the native BMP was pathogen-specific antigen would eliminate the requirement radioimmunoprecipitation, SDSfor absorbing human sera with an extract prepared from Lch fraction, the order of presentaReiter treponemes, as is now done for most commonly used me fraction solubilized in buffer confirmatory tests for syphilis (20, 51 
